AVR anteris technologies global corp.

Ann: Annual Report to shareholders, page-35

  1. 355 Posts.
    lightbulb Created with Sketch. 42
    According to my research and the annual report published few weeks ago:
    - IDE submission in Q125, ie in the next few days
    - Response by FDA within 30 days of submission
    - If IDE is approved, recruitment should start for the pivotal trial around May/ June 25
    - as we will receive around US$25,000 for each implant, so technically speaking we will be generating revenue
    - PMA could be by the end of 2027

    Not advice, DYOR
    Last edited by codeai: 26/03/25
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$5.55
Change
-0.010(0.18%)
Mkt cap ! $85.91M
Open High Low Value Volume
$5.31 $5.60 $5.31 $52.23K 9.674K

Buyers (Bids)

No. Vol. Price($)
1 188 $5.31
 

Sellers (Offers)

Price($) Vol. No.
$5.69 122 1
View Market Depth
Last trade - 15.11pm 08/08/2025 (20 minute delay) ?
AVR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.